CI
BIIB icon

CX Institutional’s Biogen BIIB Stock Holding History

CX Institutional’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Sell
1,701
-24
-1% -$4.59K 0.01% 554
2026
Q1 		$316K Buy
1,725
+19
+1% +$3.5K 0.01% 589
2025
Q4 		$300K Buy
1,706
+253
+17% +$41.3K 0.01% 584
2025
Q3 		$204K Buy
1,453
+83
+6% +$11.2K 0.01% 689
2025
Q2 		$172K Buy
1,370
+55
+4% +$6.85K 0.01% 674
2025
Q1 		$180K Buy
+1,315
New +$188K 0.01% 626
2024
Q3 		– Sell
-1,005
Closed -$233K – 556
2024
Q2 		$233K Buy
+1,005
New +$218K 0.01% 507
2024
Q1 		– Sell
-865
Closed -$224K – 546
2023
Q4 		$224K Buy
+865
New +$212K 0.01% 469
2023
Q3 		– Sell
-712
Closed -$203K – 487
2023
Q2 		$203K Buy
+712
New +$212K 0.01% 500
2022
Q3 		– Sell
-93
Closed -$19K – 525
2022
Q2 		$19K Buy
+93
New +$19K ﹤0.01% 850
2021
Q4 		– Sell
-320
Closed -$91K – 392
2021
Q3 		$91K Sell
320
-15
-4% -$4.92K 0.01% 464
2021
Q2 		$116K Buy
335
+97
+41% +$29.4K 0.01% 416
2021
Q1 		$67K Buy
238
+30
+14% +$8.09K 0.01% 430
2020
Q4 		$51K Buy
208
+63
+43% +$16.3K ﹤0.01% 434
2020
Q3 		$41K Buy
145
+77
+113% +$21.5K ﹤0.01% 417
2020
Q2 		$18K Sell
68
-19
-22% -$5.71K ﹤0.01% 460
2020
Q1 		$28K Buy
87
+30
+53% +$9.1K ﹤0.01% 343
2019
Q4 		$17K Buy
57
+36
+171% +$9.99K ﹤0.01% 362
2019
Q3 		$5K Sell
21
-32
-60% -$7.45K ﹤0.01% 568
2019
Q2 		$12K Buy
53
+1
+2% +$231 ﹤0.01% 456
2019
Q1 		$12K Buy
+52
New +$16.4K ﹤0.01% 434

Other funds holding BIIB

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CX Institutional's BIIB Position: Q2 2026 in Review

CX Institutional reduced its Biogen (BIIB) stake by 1.4% in Q2 2026, selling an estimated $4.59K and leaving 1,701 shares worth $368K. The position accounts for 0.01% of the portfolio, ranked #554.

CX Institutional first reported a position in BIIB in Q1 2019 and has held it in 21 quarters since. 161 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • CX Institutional held 1,701 shares of Biogen worth $368K as of Q2 2026.
  • CX Institutional sold 24 Biogen shares in Q2 2026, an estimated $4.59K.
  • Biogen made up 0.01% of CX Institutional's portfolio in Q2 2026, its #554 holding.
  • CX Institutional first reported a position in Biogen in Q1 2019 and has held it in 21 quarters since.
  • 161 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.